<DOC>
	<DOCNO>NCT02280473</DOCNO>
	<brief_summary>This study evaluate safety efficacy new eye drop formulation patient dry eye disease .</brief_summary>
	<brief_title>A Safety Efficacy Study New Eye Drop Formulation Patients With Dry Eye Disease</brief_title>
	<detailed_description />
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Tetrahydrozoline</mesh_term>
	<mesh_term>Carboxymethylcellulose Sodium</mesh_term>
	<criteria>Current use artificial tear product Visual acuity least 20/32 ( wear glass , necessary ) . Use contact lens last 3 month , anticipate use contact lenses study Cataract surgery , laserassisted situ keratomileusis [ LASIK ] , photorefractive keratectomy , within last 6 month Current eye infection inflammation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>